Study to Compare the Pharmacokinetics, Safety and Tolerability of the Pediatric and Adult Branaplam Formulation in Healthy Adults and the Effect of Food on the Latter.

NCT05330286 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped The compound is no longer suitable for further clinical development due to a safety finding in a later phase program.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals